The results (Fig. S8) indicated that the mRNA levels of ANLN, ARNTL2, CDKN3, and FAM53B in the cancer cell lines (SW 1990, BxPC-3, CFPAC-1, and PANC-1) were significantly higher than those in the normal cell line (HPDE), indicating their prognostic value. This evidence concerns the gene BMAL2 and cancer.